title: Part one: for the motion. young patients with good risk factors should be treated with EVAR.
authors.affiliation: Division of Vascular Surgery, University of North Carolina, Chapel Hill, NC, USA.
authors.forename: R
authors.initials: R
authors.lastname: Vallabhaneni
authors.forename: M A
authors.initials: MA
authors.lastname: Farber
mesh_terms: D000367:Age Factors; D017544:Aortic Aneurysm, Abdominal / Q000628:therapy*; D057510:Endovascular Procedures; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008017:Life Expectancy; D057240:Patient Preference; D018579:Patient Selection; D062707:Return to Work; D018570:Risk Assessment
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors